Condition
Recurrent WHO Grade III Glioma clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Recurrent WHO Grade III Glioma clinical trials that are recruiting, at sites in 6 countries (most in United States (2), Australia (1), Israel (1)). By phase: Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 6Countries
All recruiting trials (2)
-
Combination therapy for treating diffuse midline gliomas
This study is testing a new combination of treatments for people with diffuse midline gliomas to see if it can help them live longer and feel better.
-
Using advanced MRI techniques to evaluate lower grade gliomas
This study is testing if advanced MRI techniques can help doctors better understand and track the growth of lower grade brain tumors in patients.
Related topics
Quick answers
How many Recurrent WHO Grade III Glioma clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in United States (2 trials), Australia (1 trial), Israel (1 trial), Netherlands (1 trial), New Zealand (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.